Different metabolism of vitamin D2 and vitamin D3 in epileptic patients on carbamazepine.
Serum concentrations of vitamin D metabolites were measured in 30 epileptic outpatients on monotherapy with carbamazepine before and during treatment with either vitamin D2 or vitamin D3, 4000 IU per day for 24 weeks. Vitamin D2 treatment increased the serum concentration of 25OHD2, but a corresponding decrease in 25OHD3 resulted in an unchanged serum value of total 25OHD. Vitamin D3 treatment increased the serum concentration of 25OHD3. The resulting serum level of 25OHD was consequently twice the level of that in the D2-treated group. The serum concentrations of the dihydroxy metabolites showed a similar difference between the 2 treatment groups. We conclude that treatment with vitamins D2 and D3 in the same doses produces considerably different serum concentrations of vitamin D metabolites. If the present findings can be extrapolated to normal subjects, it is important to consider more carefully which D-vitamin should be used, both with regard to therapy and supplementation.
Tjellesen
L
L
Christiansen
C
C
Rødbro
P
P
Hummer
L
L
D000328:Adult; D000368:Aged; D002220:Carbamazepine / Q000627:therapeutic use*; D002762:Cholecalciferol / Q000097:blood*; D004827:Epilepsy / Q000097:blood / Q000188:drug therapy*; D004872:Ergocalciferols / Q000097:blood*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged
D004872:Ergocalciferols; D002762:Cholecalciferol; D002220:Carbamazepine